Surgical Outcome and Differences on Histopathology in Patients With Alcoholic & Non Alcoholic Chronic Pancreatitis
NCT ID: NCT02048267
Last Updated: 2014-11-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
24 participants
OBSERVATIONAL
2012-01-31
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Although it is well known that pain is the main symptom of chronic pancreatitis, it has until now been assessed in very common and varying categories. Pain, however, is only one aspect of the large variety of sensitive facets of daily life. In addition to an improvement in pain symptoms and the preservation of pancreatic exocrine and endocrine function and other parameters, occupational rehabilitation of these mostly young patients and quality of life also should be considered in the evaluation of surgical outcome in alcoholic and non-alcoholic chronic pancreatitis.
In this prospective study, we intend to find out if there are any differences in the surgical outcome on the above mentioned parameters in alcoholic and non-alcoholic chronic pancreatitis.We also plan to see if there are differences in the histopathology in these two disease settings.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Alcoholic
Frey's procedure/Pylorus preserving pancreatoduodenectomy
Duodenum preserving head resection
Non alcoholic
Frey's procedure/Pylorus preserving pancreatoduodenectomy
Duodenum preserving head resection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Frey's procedure/Pylorus preserving pancreatoduodenectomy
Duodenum preserving head resection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Typical Chronic epigastric abdominal pain
2. Elevation of serum Amylase\>3 times upper limit normal or
3. Fecal elastase less than 200ug/g stool.
4. Confirmatory findings on cross-sectional imaging:
1. Changes in size, shape and contour of pancreas
2. Dilatation of main pancreatic duct
3. Calcification
4. Pseudocyst
5. Pancreatic duct stricture
5. Patients who fulfill the criteria for surgical intervention
Exclusion Criteria
* On going acute pancreatitis
* Postop alcohol intake
* Pregnancy.
* Chronic pancreatitis with Malignancy
15 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Post Graduate Institute of Medical Education and Research, Chandigarh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rajesh Gupta
Additional Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rajesh Gupta, M.Ch.
Role: PRINCIPAL_INVESTIGATOR
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Postgraduate Institute of Medical Education and Research
Chandigarh, Chandigarh, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NK/338/MS/9609-1
Identifier Type: -
Identifier Source: org_study_id